Related Experiment Videos

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

Thomas P Lodise1, Ben Lomaestro, Jeffrey Graves

  • 1Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208, USA. Lodiset@acp.edu

Antimicrobial Agents and Chemotherapy
|January 30, 2008
PubMed

Insights

Higher vancomycin doses (≥4 g/day) are linked to increased nephrotoxicity compared to standard doses or linezolid. This finding highlights potential kidney risks associated with aggressive vancomycin dosing strategies.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Current guidelines recommend vancomycin trough concentrations of 15-20 mg/L.
  • Some clinicians have escalated vancomycin dosing to ≥4 g/day in response.
  • Limited data exist on toxicities associated with these higher vancomycin doses.

Purpose of the Study:

  • To investigate the association between high-dose vancomycin (≥4 g/day) and nephrotoxicity.
  • To compare nephrotoxicity rates between high-dose vancomycin, standard-dose vancomycin, and linezolid.

Main Methods:

  • A cohort study included patients receiving vancomycin or linezolid (2005-2006).
  • Inclusion criteria: age ≥18, non-neutropenic, therapy >48h, baseline creatinine <2.0 mg/dL, no cystic fibrosis, no recent IV contrast.
  • Nephrotoxicity defined as serum creatinine increase ≥0.5 mg/dL or ≥50%; analyzed using Kaplan-Meier and Cox modeling.

Main Results:

  • Nephrotoxicity occurred in 34.6% of high-dose vancomycin patients vs. 10.9% of standard-dose and 6.7% of linezolid patients (P=0.001).
  • Kaplan-Meier analysis showed significantly shorter time to nephrotoxicity in the high-dose vancomycin group.
  • Independent predictors of nephrotoxicity included high-dose vancomycin, weight ≥101.4 kg, creatinine clearance ≤86.6 mL/min, and ICU stay.

Conclusions:

  • Higher vancomycin dosing regimens (≥4 g/day) are associated with an increased risk of nephrotoxicity.
  • Clinicians should carefully consider the risk-benefit profile when prescribing high-dose vancomycin.
  • Further research may be warranted to optimize dosing strategies and minimize renal adverse events.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...